Article
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
Blood - 15 Jun 2017
Rahman Sunniyat, Magnussen Michael, León Theresa E, Farah Nadine, Li Zhaodong, Abraham Brian J, Alapi Krisztina Z, Mitchell Rachel J, Naughton Tom, Fielding Adele K, Pizzey Arnold, Bustraan Sophia, Allen Christopher, Popa Teodora, Pike-Overzet Karin, Garcia-Perez Laura, Gale Rosemary E, Linch David C, Staal Frank J T, Young Richard A, Look A Thomas, Mansour Marc R
Abstract excerpt
Somatic mutations within noncoding genomic regions that aberrantly activate oncogenes have remained poorly characterized. Here we describe recurrent activating intronic mutations of LMO2, a prominent oncogene in T-cell acute lymphoblastic leukemia (T-ALL). Heterozygous mutations were identified in PF-382 and DU.528 T-ALL cell lines in addition to 3.7% of pediatric (6 of 160) and 5.5% of adult (9 of 163) T-ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
